These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9234038)
1. Ability to counselors to detect cognitive impairment among substance-abusing patients: an examination of diagnostic efficiency. Fals-Stewart W Exp Clin Psychopharmacol; 1997 Feb; 5(1):39-50. PubMed ID: 9234038 [TBL] [Abstract][Full Text] [Related]
2. Detection of neuropsychological impairment among substance-abusing patients: accuracy of the neurobehavioral cognitive status examination. Fals-Stewart W Exp Clin Psychopharmacol; 1997 Aug; 5(3):269-76. PubMed ID: 9260075 [TBL] [Abstract][Full Text] [Related]
3. The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module. Grohman K; Fals-Stewart W Exp Clin Psychopharmacol; 2004 Aug; 12(3):200-7. PubMed ID: 15301637 [TBL] [Abstract][Full Text] [Related]
4. Intermediate length neuropsychological screening of impairment among psychoactive substance-abusing patients: a comparison of two batteries. Fals-Stewart W J Subst Abuse; 1996; 8(1):1-17. PubMed ID: 8743765 [TBL] [Abstract][Full Text] [Related]
5. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia. Wobrock T; Sittinger H; Behrendt B; D'Amelio R; Falkai P; Caspari D Eur Arch Psychiatry Clin Neurosci; 2007 Jun; 257(4):203-10. PubMed ID: 17131214 [TBL] [Abstract][Full Text] [Related]
6. Utility of a brief cognitive screening instrument in substance abuse patients: initial investigation. Gillen RW; Kranzler HR; Kadden RM; Weidenman MA J Subst Abuse Treat; 1991; 8(4):247-51. PubMed ID: 1664866 [TBL] [Abstract][Full Text] [Related]
7. The neuropsychological test performance of drug-abusing patients: an examination of latent cognitive abilities and associated risk factors. Fals-Stewart W; Bates ME Exp Clin Psychopharmacol; 2003 Feb; 11(1):34-45. PubMed ID: 12622342 [TBL] [Abstract][Full Text] [Related]
8. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment. Ridley N; Batchelor J; Draper B; Demirkol A; Lintzeris N; Withall A J Clin Exp Neuropsychol; 2018 Mar; 40(2):107-122. PubMed ID: 28436744 [TBL] [Abstract][Full Text] [Related]
9. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder. Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572 [TBL] [Abstract][Full Text] [Related]
10. Professional confidence and job satisfaction: an examination of counselors' perceptions in faith-based and non-faith-based drug treatment programs. Chu DC; Sung HE Int J Offender Ther Comp Criminol; 2014 Aug; 58(8):975-92. PubMed ID: 23788288 [TBL] [Abstract][Full Text] [Related]
11. A comparison of substance abuse patients' and counselors' perceptions of relapse risk: relationship to actual relapse. Walton MA; Blow FC; Booth BM J Subst Abuse Treat; 2000 Sep; 19(2):161-9. PubMed ID: 10963927 [TBL] [Abstract][Full Text] [Related]
12. Cognitive effects of cocaine and polydrug abuse. Rosselli M; Ardila A J Clin Exp Neuropsychol; 1996 Feb; 18(1):122-35. PubMed ID: 8926291 [TBL] [Abstract][Full Text] [Related]
13. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders]. Liraud F; Verdoux H Encephale; 2002; 28(2):160-8. PubMed ID: 11972143 [TBL] [Abstract][Full Text] [Related]
14. Treatment structure, client coping methods, and response to brief individual counseling: preliminary findings in a substance dependent sample. Gottheil E; Thornton CC; Weinstein SP J Addict Dis; 1997; 16(3):51-65. PubMed ID: 9243340 [TBL] [Abstract][Full Text] [Related]
15. Do patients' perceptions of their counselors influence outcomes of drug treatment? Kasarabada ND; Hser YI; Boles SM; Huang YC J Subst Abuse Treat; 2002 Dec; 23(4):327-34. PubMed ID: 12495794 [TBL] [Abstract][Full Text] [Related]
17. Psychometric vs. attentional correlates of early onset alcohol and substance abuse. Pogge DL; Stokes J; Harvey PD J Abnorm Child Psychol; 1992 Apr; 20(2):151-62. PubMed ID: 1593024 [TBL] [Abstract][Full Text] [Related]
18. Neurocognitive profiles of marginally housed persons with comorbid substance dependence, viral infection, and psychiatric illness. Gicas KM; Vila-Rodriguez F; Paquet K; Barr AM; Procyshyn RM; Lang DJ; Smith GN; Baitz HA; Giesbrecht CJ; Montaner JS; Krajden M; Krausz M; MacEwan GW; Panenka WJ; Honer WG; Thornton AE J Clin Exp Neuropsychol; 2014; 36(10):1009-22. PubMed ID: 25380059 [TBL] [Abstract][Full Text] [Related]
19. Assessment of Executive Function in Patients With Substance Use Disorder: A Comparison of Inventory- and Performance-Based Assessment. Hagen E; Erga AH; Hagen KP; Nesvåg SM; McKay JR; Lundervold AJ; Walderhaug E J Subst Abuse Treat; 2016 Jul; 66():1-8. PubMed ID: 27211990 [TBL] [Abstract][Full Text] [Related]
20. Relation of premorbid cognitive abilities to substance users' problems at treatment intake and improvements with substance abuse treatment and case management. Block RI; Bates ME; Hall JA Am J Drug Alcohol Abuse; 2003 Aug; 29(3):515-38. PubMed ID: 14510038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]